Acemetacin is a nonsteroidal anti-inflammatory drug (NSAID) used for the treatment of pain and inflammation. However, during the synthesis process, impurities may be generated. These impurities can affect the purity, efficacy, and safety of the drug product. Therefore, it is important to identify and control these impurities during the manufacturing process to ensure the quality of the final product. The most commonly observed impurities in acemetacin are related to the starting materials, reagents, and intermediates used in the synthesis process.
